Full Text View
Tabular View
No Study Results Posted
Related Studies
Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria
This study has been completed.
Study NCT00055198   Information provided by Cubist Pharmaceuticals
First Received: February 20, 2003   Last Updated: January 30, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gram-Positive Bacterial Infections
Additional conditions recognized in this trial
Bacterial Infections
Communicable Diseases
Infection
Interventions listed in this trial
daptomycin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Cubist Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services